globalfinancialengineering

Why I am bullish on Achillion Pharmaceuticals, Inc. (ACHN)

Long
NASDAQ:ACHN   None
Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes small molecule drug therapies for immune system disorders in the United States. Its lead drug candidate includes ACH-4471, an inhibitor of factor D that is Phase II clinical trials for patients with paroxysmal nocturnal hemoglobinuria and C3 glomerulopathy.

Decide to enter a bullish trade at $1.63 after crossing above the EMA(10). This a very affordable stock but is also risky trade. Therefore using a trailing stop is a must on this trade..


----------------------------
This post is for general information purposes only. It is not investment advice or a solution to buy or sell securities.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.